Intensive Care Medicine

, Volume 34, Issue 10, pp 1851–1857

Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass

  • John S. GiulianoJr
  • Patrick M. Lahni
  • Michael T. Bigham
  • Peter B. Manning
  • David P. Nelson
  • Hector R. Wong
  • Derek S. Wheeler
Original

DOI: 10.1007/s00134-008-1174-9

Cite this article as:
Giuliano, J.S., Lahni, P.M., Bigham, M.T. et al. Intensive Care Med (2008) 34: 1851. doi:10.1007/s00134-008-1174-9
  • 112 Downloads

Abstract

Objective

The aim was to investigate the effects of cardiopulmonary bypass (CPB) on plasma levels of the vascular growth factors, angiopoietin (angpt)-1, angpt-2, and vascular endothelial growth factor (VEGF).

Design

The design was a prospective, clinical investigation.

Setting

The setting was a 12-bed pediatric cardiac intensive care unit of a tertiary children’s medical center.

Patients

The patients were 48 children (median age, 5 months) undergoing surgical correction or palliation of congenital heart disease who were prospectively enrolled following informed consent.

Interventions

There were no interventions in this study.

Measurements and results

Plasma samples were obtained at baseline and at 0, 6, and 24 h following CPB. Angpt-1, angpt-2, and VEGF levels were measured via commercial ELISA. Angpt-2 levels increased by 6 h (0.95, IQR 0.43–2.08 ng mL−1 vs. 4.62, IQR 1.16–6.93 ng mL−1, P < 0.05) and remained significantly elevated at 24 h after CPB (1.85, IQR 0.70–2.76 ng mL−1; P < 0.05). Angpt-1 levels remained unchanged immediately after CPB, but were significantly decreased at 24 h after CPB (0.64, IQR 0.40–1.62 ng mL−1 vs. 1.99, IQR 1.23–2.63 ng mL−1, P < 0.05). Angpt-2 levels correlated significantly with cardiac intensive care unit (CICU) length of stay (LOS) and were an independent predictor for CICU LOS on subsequent multivariate analysis.

Conclusions

Angpt-2 appears to be an important biomarker of adverse outcome following CPB in children.

Keywords

Vascular growth factor Cardiopulmonary bypass Inflammation Pediatrics Congenital heart disease Systemic inflammatory response syndrome (SIRS) 

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • John S. GiulianoJr
    • 1
    • 2
  • Patrick M. Lahni
    • 1
    • 2
    • 3
  • Michael T. Bigham
    • 1
    • 2
  • Peter B. Manning
    • 4
    • 5
  • David P. Nelson
    • 6
    • 7
  • Hector R. Wong
    • 1
    • 2
    • 3
  • Derek S. Wheeler
    • 1
    • 2
    • 3
  1. 1.Division of Critical Care MedicineCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  2. 2.Department of PediatricsUniversity of Cincinnati College of MedicineCincinnatiUSA
  3. 3.The Kindervelt Laboratory for Critical Care Medicine ResearchCincinnati Children’s Research FoundationCincinnatiUSA
  4. 4.Division of Cardiothoracic SurgeryCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  5. 5.Department of SurgeryUniversity of Cincinnati College of MedicineCincinnatiUSA
  6. 6.Division of CardiologyTexas Children’s HospitalHoustonUSA
  7. 7.Department of PediatricsBaylor College of MedicineHoustonUSA

Personalised recommendations